www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

USEUROPEAFRICAASIA 中文雙語Fran?ais
China
Home / China / Health

AstraZeneca to develop new drugs with Chinese partner

chinadaily.com.cn | Updated: 2017-11-28 14:25

AstraZeneca on Monday announced a strategic joint venture with the Chinese Future Industry Investment Fund (FIIF) to form an equally-owned, stand-alone company in China to discover, develop and commercialise potential new medicines to help meet unmet needs globally, and to bring innovative new medicines to patients in China faster. FIIF is managed by the SDIC Fund Management Company (SDIC Fund), a fully market-oriented and professional private equity management company.

The new company, Dizal Pharmaceutical, incorporates all scientific and technical capabilities of AstraZeneca's Innovation Center China (ICC), and holds exclusive rights to develop and commercialise three potential medicines currently in pre-clinical development from AstraZeneca's pipeline in its main therapy areas of oncology, cardiovascular and metabolic diseases, and respiratory. It is also expected to initiate novel clinical programmes. The SDIC Fund will contribute funding and expertise in establishing strategic partnerships in China.

Dr. Xiaolin Zhang, previously Head of AstraZeneca's ICC, has been named as Chief Executive Officer of the new company.All staff employed by the ICC have been invited to join the new company.

Pascal Soriot, Chief Executive Officer of AstraZeneca, said: "AstraZeneca has a long-standing and strong commitment to China, which we are reinforcing today with this ground-breaking joint venture. By joining forces with the SDIC Fund, we aim to accelerate the local discovery and development of innovative, affordable medicines for patientsin China and around the world."

Guohua Gao, Chairman of SDIC Fund, said: "SDIC Fund is delighted to be collaborating with AstraZeneca to promote the development of innovative medicines. AstraZeneca's Innovation Center China has an excellent track record of drug discovery, and the synergy created by combining AstraZeneca's scientific talent and assets with SDIC Fund's China expertise and funding will help further promote innovation in medical science."

The remit of the SDIC Fund in the pharmaceutical industry is to promote the development and manufacturing of innovative medicines in China through strategic partnerships. The joint venture supports AstraZeneca's commitment to enhancing China's research and development capabilities through diversified external partnerships that deliver value to patients in China.

Editor's picks
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 国产高清精品一区 | 亚洲精品一区二区三区美女 | 欧美丰满大乳大屁股毛片 | 久久99精品视免费看 | 国产精品二区三区免费播放心 | 91久久夜色精品国产网站 | 三级理论手机在线观看视频 | 免费一级欧美大片久久网 | 中文字幕在线看片成人 | 成人在线手机视频 | 天干夜天天夜天干天ww | 成人做爰视频www视频 | 日本特爽特黄特刺激大片 | 国产精品7m凸凹视频分类大全 | 大尺度福利视频在线观看网址 | 毛片免费全部免费播放 | 久久精品国产大片免费观看 | 久久永久免费视频 | 欧美一级成人免费大片 | 在线视频99 | 欧美日韩一区在线观看 | 一本不卡| 久久福利精品 | 久草视频在线播放 | 综合在线视频精品专区 | 午夜成年女人毛片免费观看 | 亚洲另类自拍 | 国产精品久久久精品视频 | 亚洲国产精品成人精品软件 | 成人ab片 | 亚洲午夜精品一区二区 | 日本一区二区三区四区不卡 | 国内精品一区二区三区最新 | 久草网在线视频 | 久久久久久久91精品免费观看 | 欧美在线播放成人免费 | 亚洲小视频在线观看 | 亚洲精品在线视频观看 | 私人毛片免费高清影视院丶 | 在线一区视频 | 美国做受三级的视频播放 |